MedTrace Logo

Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV

NCT05154513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2026-01-13

No results posted yet for this study

Summary

IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the study.

Conditions

  • HIV Infection

Interventions

OTHER

Cohort 1

No intervention provided in this study

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • International Maternal Pediatric Adolescent AIDS Clinical Trials Group

    lead NETWORK

Principal Investigators

  • Shaun Barnabas, MD, PhD · University of Stellenbosch

  • Samantha Fry, MD, MMed · University of Stellenbosch

  • Julia Rosebush, DO, FAAP · University of Chicago

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-02
Primary Completion
2025-07-30
Completion
2025-07-30

Countries

  • United States
  • Botswana
  • Brazil
  • Haiti
  • Kenya
  • Malawi
  • South Africa
  • Tanzania
  • Thailand
  • Uganda
  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05154513 on ClinicalTrials.gov